Latest news with #HealthcareSolutions
Khaleej Times
2 days ago
- Business
- Khaleej Times
Dr Manoj K. Menon named ‘AI & Healthcare Solutions Expert of the Year' at Global Fluxx Awards
Dr Manoj Menon, Group CEO of ACCRO, UAE, and ASHCONN, Qatar, has been named AI and Healthcare Solutions Expert of the Year for the region at the Global Fluxx Awards in Hong Kong. The award recognises leaders selected from over 500 global nominees across 15 countries, highlighting the region's emergence as a healthcare technology hub. Dr Menon brings 34 years of experience in healthcare technology to his current role. His career spans the GCC, USA, Spain, Australia, and India, including positions with HP, Boston Medical Centre, and GE Imaging. He holds multiple patents and has published academic papers in scientific journals while presenting at global healthcare conferences. "The GCC region represents a suitable environment for healthcare innovation," said Dr Menon. "Our goal is to develop AI tools that augment human capabilities, allowing healthcare professionals to enhance their practice across the region." Dr Menon has contributed to healthcare policy frameworks at the national level, developing guidelines that balance innovation with regulatory compliance while maintaining standards of patient safety and data security. He developed Axora, a revenue cycle management platform that uses AI to transform healthcare providers' financial operations. The platform combines predictive analytics with automation to optimise revenue capture, reduce claim denials, and enhance healthcare institutions' economic performance. The recognition aligns with regional AI strategy and ongoing healthcare digitization initiatives.
Yahoo
02-08-2025
- Business
- Yahoo
3D Systems Announces Full Commercial Release of FDA-Cleared NextDent Jetted Denture Solution, Revolutionizes Digital Dentistry
3D Systems Corporation (NYSE:DDD) is one of the tech stocks to buy according to analysts. On July 29, 3D Systems announced the full commercial release of its FDA-cleared NextDent Jetted Denture Solution for the US market. The solution represents a milestone in digital dentistry by enabling the production of multi-material and monolithic (one-piece) jetted dentures using a single printing process. The method results in a faster, more cost-effective, and highly scalable alternative to traditional denture fabrication. The core of this solution is the new NextDent 300 MultiJet 3D printer, which enables the rapid production of patient-specific dentures that are fully cured and safe to handle immediately, eliminating the need for additional post-curing steps. A closeup of a modern 3D printer, showing the intricate detail it can produce. To complement the printer, 3D Systems' materials scientists developed two FDA-cleared dental materials: NextDent Jet Teeth and NextDent Jet Base. When used together with the NextDent 300 printer, these materials provide desired tooth rigidity, gum support, outstanding aesthetics, and enhanced toughness. 3D Systems Corporation (NYSE:DDD) provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. It operates through 2 segments: Healthcare Solutions and Industrial Solutions. While we acknowledge the potential of DDD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
01-08-2025
- Business
- Yahoo
3D Systems Announces Full Commercial Release of FDA-Cleared NextDent Jetted Denture Solution, Revolutionizes Digital Dentistry
3D Systems Corporation (NYSE:DDD) is one of the tech stocks to buy according to analysts. On July 29, 3D Systems announced the full commercial release of its FDA-cleared NextDent Jetted Denture Solution for the US market. The solution represents a milestone in digital dentistry by enabling the production of multi-material and monolithic (one-piece) jetted dentures using a single printing process. The method results in a faster, more cost-effective, and highly scalable alternative to traditional denture fabrication. The core of this solution is the new NextDent 300 MultiJet 3D printer, which enables the rapid production of patient-specific dentures that are fully cured and safe to handle immediately, eliminating the need for additional post-curing steps. A closeup of a modern 3D printer, showing the intricate detail it can produce. To complement the printer, 3D Systems' materials scientists developed two FDA-cleared dental materials: NextDent Jet Teeth and NextDent Jet Base. When used together with the NextDent 300 printer, these materials provide desired tooth rigidity, gum support, outstanding aesthetics, and enhanced toughness. 3D Systems Corporation (NYSE:DDD) provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. It operates through 2 segments: Healthcare Solutions and Industrial Solutions. While we acknowledge the potential of DDD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data
Associated Press
18-06-2025
- Business
- Associated Press
Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who purchased or otherwise acquired 3D Systems Corporation (3D Systems or the Company) (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the Class Period). Investors who purchased or otherwise acquired shares of 3D Systems should contact the Firm prior to the August 12, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION The lawsuit alleges that during the Class Period, 3D Systems and certain of its executives made materially false and/or misleading statements and failed to disclose critical information, including: On March 26, 2025, 3D Systems reported disappointing financial results for Q4 and full-year 2024, including: Following this news, shares of 3D Systems fell 20.96%, closing at $2.15 per share on March 27, 2025. Subsequently, on May 12, 2025, 3D Systems issued a press release announcing its financial results for the first quarter ('Q1") of Company attributed its disappointing results, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. 3D Systems also announced that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty. On this news, 3D Systems' stock price fell $0.68 per share, or 26.6%, to close at $1.87 per share on May 13, 2025. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Why Wolf Haldenstein Adler Freeman & Herz LLP?: This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors. We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP. Contact: Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
New Straits Times
29-05-2025
- Business
- New Straits Times
UEM edgenta secures order book worth RM1.1bil in Q1, bringing total to RM9.3bil
KUALA LUMPUR: UEM Edgenta Bhd has secured an order book worth RM1.1 billion in the first quarter ended March 31, 2025 (1Q FY2025), bringing the company's cumulative order book to RM9.3 billion as at March 31, 2025. Chief financial officer Ahmad Fazril Fauzi said the RM1.1 billion represents 39 per cent of the total order book secured in FY2024. "We secured RM2.8 billion for the whole of last year, and by the first quarter of this year, we have already achieved 39 per cent of that," he said during a virtual analyst and media briefing today. Of the RM9.3 billion order book, RM5.8 billion is contributed by infrastructure services, followed by healthcare solutions (RM2.5 billion), property and facility solutions (RM600 million), and asset consultancy (RM400 million). "We are bullish on the performance going forward, supported by the positive momentum of its international operations as we secured contract wins in key markets such as Saudi Arabia, the United Arab Emirates (UAE) and Singapore. "The group's operations in Saudi Arabia and the UAE achieved a strong 24 per cent year-on-year revenue growth, driven by effective integration efforts and the scaling of newly acquired entities" he added. Elaborating further, he added that in Singapore, new contract wins amounting to RM462.8 million within the Healthcare Solutions division contributed to an encouraging order book, while additional wins in Taiwan (RM328.7 million) are also supporting the group's efforts to stabilise and strengthen its business performance. Commenting on its financial results ended March 31, 2025, Ahmad Fazril said the company is expected to return to profitability as early as the second quarter after recording losses in 1Q FY2025. He attributed the losses to cyclical factors. UEM Edgenta turned red in 1QFY2025, registering a net loss of RM17.95 million compared with RM9.77 million in the same quarter a year ago, while revenue declined to RM646.06 million versus RM677.6 million recorded previously.
